A Phase II Study to Evaluate the Safety, Pharmacokinetics, and Clinical Activity of AZD0171 in Combination with Durvalumab and Chemotherapy in Participants with Locally Advanced or Metastatic Solid Tumors

The University of Virginia is conducting a clinical research study for adults ages 18 and over, who have pancreatic cancer. This study is being done to learn more about adding the experimental drugs AZD0171 and durvalumab to the current treatment of chemotherapy (nab-paclitaxel and gemcitabine).

The total treatment duration is unknown as you will receive the study drug as long as your disease status does not worsen or no other reasons for stopping occur.

Study-related procedures that are being done beyond your standard of care will be provided at no cost to you or your insurance.

Additional information can be found here: https://clinicaltrials.gov/ct2/show/NCT04999969

uvacancertrials@hscmail.mcc.virginia.edu